Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Galantamine Hydrobromide

Galantamine Hydrobromide

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Galantamine Hydrobromide:

 BioPortfolio Logo
Watson Pharmaceuticals Receives FDA Approval for Generic Razadyne(R) ER Capsules 16th December, 2008 Watson Pharmaceuticals, Inc.
CORONA, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories,
Mylan's Alphapharm Victorious in Patent Challenge on First-to-File Opportunity Razadyne(R) Tablets 29th August, 2008 Mylan Inc.
PITTSBURGH, Aug. 29 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced that its subsidiary Alphapharm Pty Limited won a favorable decision in patent litigation against it and Barr

This page has been viewed 28 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Galantamine Hydrobromide across BioPortfolio, or for Galantamine Hydrobromide Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.